Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2SxiWqj
via IFTTT